Scientific Advisory Board

David Allen Bushinsky, M.D. Professor of Medicine and of Pharmacology and Physiology, University of Rochester School of Medicine, and Chief, Nephrology Division, University of Rochester Medical Center
John Cunningham, D.M. Professor of Nephrology, UCL Medical School, London; Consultant Nephrologist, Royal Free Hospital, London, and The London Clinic; Physician, King Edward VII Hospital, London; Head of the Medical Household to HM the Queen; and Physician to the Queen.
Bess Dawson-Hughes, M.D. Professor of Medicine, Tufts University School of Medicine, and Senior Scientist and Director, Bone Metabolism Laboratory Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Glenville Jones, Ph.D. Head of Biochemistry Department, Professor of Biochemistry & Medicine, Queen's University
Kevin Martin, M.D. Director of Research, Division of Nephrology, St. Louis University School of Medicine
L. Darryl Quarles, M.D. Director of Division of Nephrology, and Associate Dean for Research, University of Tennessee Health Science Center.
Isidro Salusky, M.D. Professor of Pediatric Medicine, David Geffen School of Medicine, and Director of Clinical Research Center, UCLA School of Medicine
Stuart Sprague, D.O. Chief, Division of Nephrology and Hypertension, North Shore University Health System, and Professor of Medicine, University of Chicago Pritzker School of Medicine
Myles Wolf, MD, MMSc Chief of the Division of Nephrology and Hypertension

David Allen Bushinsky, M.D.

John J. Kuiper Distinguished Professor of Medicine, Pharmacology and Physiology, University of Rochester School of Medicine; Chief of Nephrology Division, University of Rochester Medical Center; and Associate Chair, Academic Affairs in the Department of Medicine.

Dr. Bushinsky has published several hundred peer-reviewed articles, invited reviews, chapters and editorials focusing on disorders of divalent ion metabolism. He has developed a strain of rats that exhibit genetic hypercalciuria, the most common metabolic abnormality in humans with nephrolithiasis, and spontaneously form kidney stones. The pathophysiolgy of the hypercalciuria closely parallels that of man and is thus a useful model to study stone formation in humans. He has also extensively studied the mechanism by which metabolic acids induce physicochemical bone dissolution and cell-mediated bone resorption. His research has been consistently funded by grants from the National Institutes of Health for three decades. Dr Bushinsky has lectured throughout the world on stone formation, effects of acid on bone and other disorders of divalent ion metabolism.

Dr Bushinsky received his medical degree from Tufts University School of Medicine in Boston, Mass. He completed an internship and residency at Tufts New England Medical Center Hospital in Boston, Mass. He also completed a fellowship in clinical nephrology and a research fellowship in nephrology at Tufts New England Medical Center Hospital in Boston, Mass.

Dr Bushinsky is a member of a number of professional organizations including the Association of American Physicians and the American Society for Clinical Investigation.


© 2023 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use